Wright Medical/Orthomet
This article was originally published in The Gray Sheet
Executive Summary
Orthopedic companies make definitive their merger agreement, announced Sept. 16, under which Orthomet will become a wholly- owned subsidiary of Wright ("The Gray Sheet" Sept. 19, I&W-1). Orthomet shareholders will receive $11 per common share and $12.09 per share of 6% convertible preferred stock, valuing the deal at approximately $59.7 mil., Orthomet says